Stock Scorecard

Stock Summary for Zimmer Biomet Holdings Inc (ZBH) - $97.55 as of 11/26/2025 9:07:57 PM EST

Total Score

10 out of 30

Safety Score

61 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for ZBH

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for ZBH

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for ZBH

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for ZBH

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for ZBH (61 out of 100)

Stock Price Rating (Max of 10) 9
Historical Stock Price Rating (Max of 10) 10
Stock Price Trend (Max of 10) 2
Book Value (Max of 10) 9
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 5
Dividend Yield Percentage (Max of 10) 1
Operating Margin (Max of 10) 4
Trading Volume (Max of 10) 9
Price to Earnings (Max of 10) 7
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for ZBH

From Hospitals to ASCs: Will Refurbished Xi Systems Broaden ISRG's Reach? 11/26/2025 12:32:00 PM
Bragar Eagel & Squire, P.C. Is Investigating Gauzy and Zimmer Biomet and Encourages Investors to Contact the Firm - Zimmer Biomet Holdings ( NYSE:ZBH ) , Gauzy ( NASDAQ:GAUZ ) 11/20/2025 9:29:00 PM
Securities Fraud Investigation Into Zimmer Biomet Holdings, Inc. ( ZBH ) Continues - Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - Zimmer Biomet Holdings ( NYSE:ZBH ) 11/19/2025 8:34:00 PM
Zimmer Biomet Holdings, Inc. ( ZBH ) Shareholders Who Lost Money - Contact Law Offices of Howard G. Smith About Securities Fraud Investigation 11/19/2025 7:30:00 PM
Securities Fraud Investigation Into Zimmer Biomet Holdings, Inc. ( ZBH ) Continues - Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm - Zimmer Biomet Holdings ( NYSE:ZBH ) 11/19/2025 5:51:00 PM
Nailing Systems Market Set for Strong Growth as Demand Rises Across Orthopedic and Trauma Care Segments: Verified Market Research® 11/19/2025 3:45:00 AM
Zimmer Biomet Holdings ( ZBH ) Faces Investor Scrutiny Amid Emerging Markets Distributor Orders Cancelation, Reduced Top-Line Revenue Forecast -- Hagens Berman - Zimmer Biomet Holdings ( NYSE:ZBH ) 11/18/2025 2:37:00 AM
Why Zimmer Biomet ( ZBH ) is a Top Value Stock for the Long-Term 11/14/2025 2:40:00 PM
This Zimmer Biomet Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - BioMarin Pharmaceutical ( NASDAQ:BMRN ) , Duolingo ( NASDAQ:DUOL ) 11/6/2025 12:55:00 PM
Zimmer Biomet Q3 Earnings Top but Revenue Miss Causes Pre-Market Drop 11/5/2025 5:17:00 PM

Financial Details for ZBH

Company Overview
Ticker ZBH
Company Name Zimmer Biomet Holdings Inc
Country USA
Description Zimmer Biomet Holdings Inc. is a preeminent global medical device company that specializes in the design, manufacture, and marketing of a diverse array of orthopedic reconstructive products, as well as surgical and non-surgical solutions. Based in Warsaw, Indiana, the company is distinguished by its strong innovation pipeline and strategic collaborations, aimed at improving patient outcomes across orthopedic, surgical, and dental sectors. Zimmer Biomet’s dedication to innovation and quality positions it as a vital player in the healthcare landscape, adeptly responding to the dynamic needs of healthcare professionals and patients worldwide.
Sector Name HEALTHCARE
Industry Name MEDICAL DEVICES
Most Recent Quarter 9/30/2025
Next Earnings Date 2/4/2026

Stock Price History
Last Day Price 97.55
Price 4 Years Ago 119.50
Last Day Price Updated 11/26/2025 9:07:57 PM EST
Last Day Volume 1,731,934
Average Daily Volume 2,176,090
52-Week High 113.87
52-Week Low 85.33
Last Price to 52 Week Low 14.32%

Valuation Measures
Trailing PE 23.21
Industry PE 43.80
Sector PE 88.38
5-Year Average PE 16.06
Free Cash Flow Ratio 14.96
Industry Free Cash Flow Ratio 27.32
Sector Free Cash Flow Ratio 28.18
Current Ratio Most Recent Quarter 2.43
Total Cash Per Share 6.52
Book Value Per Share Most Recent Quarter 64.36
Price to Book Ratio 1.43
Industry Price to Book Ratio 4.15
Sector Price to Book Ratio 32.98
Price to Sales Ratio Twelve Trailing Months 2.31
Industry Price to Sales Ratio Twelve Trailing Months 5.76
Sector Price to Sales Ratio Twelve Trailing Months 15.65
Analyst Buy Ratings 6
Analyst Strong Buy Ratings 5

Share Statistics
Total Shares Outstanding 198,182,000
Market Capitalization 19,332,654,100
Institutional Ownership 100.41%

Dividends
Ex-Dividend Date 9/30/2025
Previous Dividend Amount 0.2400
Current Dividend Amount 0.2400
Total Years Dividend Increasing 0
Trailing Annual Dividend Rate 0.96
Trailing Annual Dividend Yield 0.99%
Forward Annual Dividend Rate 0.96
Forward Annual Dividend Yield 0.99%
5-Year Dividend Payments Count 20
3-Year Average Dividend Yield 0.92%
5-Year Average Dividend Yield 0.82%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 2.43%
Dividend Payout Ratio 23.82%

Income Statement
Quarterly Earnings Growth YOY -5.70%
Annual Earnings Growth -11.74%
Reported EPS 12 Trailing Months 4.03
Reported EPS Past Year 5.78
Reported EPS Prior Year 8.00
Net Income Twelve Trailing Months 805,200,000
Net Income Past Year 903,800,000
Net Income Prior Year 1,024,000,000
Quarterly Revenue Growth YOY 9.70%
5-Year Revenue Growth -0.77%
Operating Margin Twelve Trailing Months 17.00%

Balance Sheet
Total Cash Most Recent Quarter 1,292,700,000
Total Cash Past Year 525,500,000
Total Cash Prior Year 415,800,000
Net Cash Position Most Recent Quarter -6,219,900,000
Net Cash Position Past Year -4,816,100,000
Long Term Debt Past Year 5,341,600,000
Long Term Debt Prior Year 5,012,600,000
Total Debt Most Recent Quarter 7,512,600,000
Equity to Debt Ratio Past Year 0.70
Equity to Debt Ratio Most Recent Quarter 0.63
Total Stockholder Equity Past Year 12,468,100,000
Total Stockholder Equity Prior Year 12,480,500,000
Total Stockholder Equity Most Recent Quarter 12,756,500,000

Free Cash Flow
Free Cash Flow Twelve Trailing Months 1,346,900,000
Free Cash Flow Per Share Twelve Trailing Months 6.80
Free Cash Flow Past Year 1,142,600,000
Free Cash Flow Prior Year 1,187,100,000

Options
Put/Call Ratio 0.28
Has Options Options Chain
Liquidity Rating

Technical Analysis
Yahoo Finance Chart Yahoo Finance Chart
MACD -2.99
MACD Signal -2.48
20-Day Bollinger Lower Band 86.71
20-Day Bollinger Middle Band 98.18
20-Day Bollinger Upper Band 109.66
Beta 0.61
RSI 35.55
50-Day SMA 100.28
150-Day SMA 112.42
200-Day SMA 112.37

System
Modified 11/25/2025 12:36:54 PM EST